Pioglitazone Therapy of PAX8-PPARγ Fusion Protein Thyroid Carcinoma

CONTEXT: A subset of thyroid carcinomas expresses an oncogenic paired box 8 (PAX8) and peroxisome proliferator activated receptor γ (PPARγ) fusion protein (PPFP). The PPARγ/PPFP ligand pioglitazone is highly therapeutic in a transgenic mouse model of PPFP thyroid carcinoma, but whether pioglitazone...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Endocrinol Metab
Autors principals: Giordano, Thomas J, Haugen, Bryan R, Sherman, Steven I, Shah, Manisha H, Caoili, Elaine M, Koenig, Ronald J
Format: Artigo
Idioma:Inglês
Publicat: Endocrine Society 2018
Matèries:
Case Reports
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6456920/
https://ncbi.nlm.nih.gov/pubmed/29373711
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2017-02533
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars